港股異動 | 績後獲投行唱好 中廣核新能源(1811.HK)大漲超9%破頂
格隆匯8月30日丨中廣核新能源(1811.HK)再度拉昇漲超9%,月內股價飆漲逾50%。盤中最高報4.68港元創歷史新高價,暫成交8728萬港元,總市值首次觸及200億港元大關。中廣核新能源日前公佈,中期純利1.62億美元,同比上升55.6%。國信證券指出,公司新增併網疊加資源改善,中報業績增速亮眼。此外,風光資源改善,在運發電項目利用小時數提升顯著,推動業績快速增長。該行預計到2025年底,公司權益裝機容量將從7.55GW增長至15.85GW,其中新能源裝機從4.1GW增長至12.4GW。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.